Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Prosch

Showing results (111-120 of 230) with videos related to

Pageof 23
Sort By:
Der Radiologe|September 16, 2021
[Morphological and functional sequelae after COVID-19 pneumonia]Ruxandra-Iulia Milos, Daria Kifjak, Benedikt H Heidinger, et al.
Der Radiologe|January 8, 2022
[Chest radiography findings in diffuse parenchymal lung diseases]Daria Kifjak, Johannes Leitner, Raphael Ambros, et al.
Current Opinion in Oncology|November 11, 2025
Beyond the usual - Atypical imaging presentation in lung cancer and implications for TNM-stagingDaria Kifjak, Rebecca Mura, Svitlana Pochepnia, et al.
Targeted Oncology|December 13, 2018
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to OsimertinibMaximilian J Hochmair, Anna Buder, Sophia Schwab, et al.
Emerging Infectious Diseases|November 4, 2008
Successful treatment of disseminated Acanthamoeba sp. infection with miltefosineAlexander C Aichelburg, Julia Walochnik, Ojan Assadian, et al.
The Journal of Pediatrics|May 4, 2010
Central nervous system disease in Langerhans cell histiocytosisNicole Grois, Bernhard Fahrner, Robert J Arceci, et al.
Radiologie (Heidelberg, Germany)|January 30, 2023
[Mediastinum-new compartment classification]Sebastian Röhrich, Benedikt H Heidinger, Florian Prayer, et al.
Life (Basel, Switzerland)|January 26, 2024
Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[<sup>18</sup>F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular InflammationRaffaella Calabretta, Lucian Beer, Helmut Prosch, et al.
Heliyon|February 10, 2025
Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020sBerta Mosleh, Pavla Sarova, Sonja Zehetmayer, et al.
Current Opinion in Oncology|November 13, 2019
Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancerWieland Voigt, Christian Manegold, Lothar Pilz, et al.
Pageof 23

Showing results (111-120 of 230) with videos related to

Sort By:
Pageof 23
Der Radiologe|September 16, 2021
[Morphological and functional sequelae after COVID-19 pneumonia]Ruxandra-Iulia Milos, Daria Kifjak, Benedikt H Heidinger, et al.
Der Radiologe|January 8, 2022
[Chest radiography findings in diffuse parenchymal lung diseases]Daria Kifjak, Johannes Leitner, Raphael Ambros, et al.
Current Opinion in Oncology|November 11, 2025
Beyond the usual - Atypical imaging presentation in lung cancer and implications for TNM-stagingDaria Kifjak, Rebecca Mura, Svitlana Pochepnia, et al.
Targeted Oncology|December 13, 2018
Liquid-Biopsy-Based Identification of EGFR T790M Mutation-Mediated Resistance to Afatinib Treatment in Patients with Advanced EGFR Mutation-Positive NSCLC, and Subsequent Response to OsimertinibMaximilian J Hochmair, Anna Buder, Sophia Schwab, et al.
Emerging Infectious Diseases|November 4, 2008
Successful treatment of disseminated Acanthamoeba sp. infection with miltefosineAlexander C Aichelburg, Julia Walochnik, Ojan Assadian, et al.
The Journal of Pediatrics|May 4, 2010
Central nervous system disease in Langerhans cell histiocytosisNicole Grois, Bernhard Fahrner, Robert J Arceci, et al.
Radiologie (Heidelberg, Germany)|January 30, 2023
[Mediastinum-new compartment classification]Sebastian Röhrich, Benedikt H Heidinger, Florian Prayer, et al.
Life (Basel, Switzerland)|January 26, 2024
Induction of Arterial Inflammation by Immune Checkpoint Inhibitor Therapy in Lung Cancer Patients as Measured by 2-[<sup>18</sup>F]FDG Positron Emission Tomography/Computed Tomography Depends on Pre-Existing Vascular InflammationRaffaella Calabretta, Lucian Beer, Helmut Prosch, et al.
Heliyon|February 10, 2025
Sex-based differences in lung cancer susceptibility and molecular genetics in the 2020sBerta Mosleh, Pavla Sarova, Sonja Zehetmayer, et al.
Current Opinion in Oncology|November 13, 2019
Beyond tissue biopsy: a diagnostic framework to address tumor heterogeneity in lung cancerWieland Voigt, Christian Manegold, Lothar Pilz, et al.
Pageof 23